These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2859158)

  • 1. The pharmacokinetics of cyclosporine. II. Blood plasma distribution and binding studies.
    Awni WM; Sawchuk RJ
    Drug Metab Dispos; 1985; 13(2):133-8. PubMed ID: 2859158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics of cyclosporine. I. Single dose and constant rate infusion studies in the rabbit.
    Awni WM; Sawchuk RJ
    Drug Metab Dispos; 1985; 13(2):127-32. PubMed ID: 2859157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of age and dose on the pharmacokinetics of ibuprofen in the rat.
    Satterwhite JH; Boudinot FD
    Drug Metab Dispos; 1991; 19(1):61-7. PubMed ID: 1673423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma protein binding of ceftriaxone.
    Popick AC; Crouthamel WG; Bekersky I
    Xenobiotica; 1987 Oct; 17(10):1139-45. PubMed ID: 3424863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporine disposition in the dog. Comparison of radioimmunoassay with high-performance liquid chromatographic assay and pharmacokinetics following intravenous administration.
    Buice RG; Gurley BJ; Stentz FB; Sidhu P; McClellan T; Williams JW
    Transplantation; 1985 Nov; 40(5):483-8. PubMed ID: 4060219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of prednisone and prednisolone at steady state in the rabbit.
    Unadkat JD; Rowland M
    Drug Metab Dispos; 1985; 13(4):503-9. PubMed ID: 2863117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of plasma protein binding on quinidine kinetics in the rabbit.
    Guentert TW; Oie S
    J Pharmacol Exp Ther; 1980 Oct; 215(1):165-71. PubMed ID: 7452481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placental transfer, tissue distribution, and pharmacokinetics of cyclosporine in the pregnant rabbit.
    Sangalli L; Bortolotti A; Passerini F; Bonati M
    Drug Metab Dispos; 1990; 18(1):102-6. PubMed ID: 1970768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of cyclosporine A interactions with human plasma lipoproteins in vitro and in vivo in the rat.
    Urien S; Zini R; Lemaire M; Tillement JP
    J Pharmacol Exp Ther; 1990 Apr; 253(1):305-9. PubMed ID: 2329513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disposition of tacrolimus (FK 506) in rabbits. Role of red blood cell binding in hepatic clearance.
    Piekoszewski W; Chow FS; Jusko WJ
    Drug Metab Dispos; 1993; 21(4):690-8. PubMed ID: 7690698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic aspects of cyclosporine therapy: pharmacokinetics.
    Wood AJ; Lemaire M
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):27-32. PubMed ID: 3895666
    [No Abstract]   [Full Text] [Related]  

  • 12. The plasma time course of orally-administered cyclosporine in the dog.
    Buice RG; Gurley BJ; Sidhu P
    Res Commun Chem Pathol Pharmacol; 1985 Oct; 50(1):143-6. PubMed ID: 4081308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporine pharmacokinetics in rats and interspecies comparison in dogs, rabbits, rats, and humans.
    Sangalli L; Bortolotti A; Jiritano L; Bonati M
    Drug Metab Dispos; 1988; 16(5):749-53. PubMed ID: 2906601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in drug plasma concentrations of an extensively bound and highly extracted drug, propofol, in response to altered plasma binding.
    Hiraoka H; Yamamoto K; Okano N; Morita T; Goto F; Horiuchi R
    Clin Pharmacol Ther; 2004 Apr; 75(4):324-30. PubMed ID: 15060510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of L-738,167, a potent and long-acting fibrinogen receptor antagonist, in dogs. Dose-dependent pharmacokinetics.
    Prueksaritanont T; Gorham LM; Naue JA; Hamill TG; Askew BC; Vyas KP
    Drug Metab Dispos; 1997 Mar; 25(3):355-61. PubMed ID: 9172954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute dose-dependent disposition studies of nicotinic acid in rats.
    Iwaki M; Ogiso T; Hayashi H; Tanino T; Benet LZ
    Drug Metab Dispos; 1996 Jul; 24(7):773-9. PubMed ID: 8818575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered dose-to-effect of propofol due to pharmacokinetics in rats with experimental diabetes mellitus.
    Leal N; Calvo R; Agrad FZ; Lukas JC; de la Fuente L; Suarez E
    J Pharm Pharmacol; 2005 Mar; 57(3):317-25. PubMed ID: 15807987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients.
    Bellnier DA; Greco WR; Loewen GM; Nava H; Oseroff AR; Pandey RK; Tsuchida T; Dougherty TJ
    Cancer Res; 2003 Apr; 63(8):1806-13. PubMed ID: 12702566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of cyclosporine in toxicological studies.
    Donatsch P; Ryffel B
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):71-6. PubMed ID: 3097895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiologically based pharmacokinetic model for cefazolin in rabbits and its preliminary extrapolation to man.
    Tsuji A; Nishide K; Minami H; Nakashima E; Terasaki T; Yamana T
    Drug Metab Dispos; 1985; 13(6):729-39. PubMed ID: 2867880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.